| License: Creative Commons Attribution 4.0 PDF - Published Version (586kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-452406
- DOI to cite this document:
- 10.5283/epub.45240
Abstract
Background: The role of venovenous extracorporeal membrane oxygenation (VV ECMO) in patients with COVID-19-induced acute respiratory distress syndrome (ARDS) still remains unclear. Our aim was to investigate the clinical course and outcome of those patients and to identify factors associated with the need for prolonged ECMO therapy. Methods: A retrospective single-center study on patients with ...

Owner only: item control page